HomeINSECTICID › Filing
🔔 Get instant alerts when INSECTICID files quarterly results on BSE Start free trial →

Investor Presentation

Filed: 11 Aug 2026, 15:03 IST Exchange: NSE Category: Financial Results — Investor Presentation
Investor Presentation - Q1FY27 - Revenue 612cr -12% y-y; EBITDA 68cr -20% y-y; PAT 44cr -24% y-y - Gross profit margin improved to 31.6% from 29.2% in Q1FY26 - Premium product share in B2C increased to 75% from 64% - Focus on innovation, expanded distribution to 8,500+ distributors - Collaboration with Corteva Agriscience to enhance crop solutions - Manufacturing capacity includes 6 formulation and 2 technical plants - Export presence in 22 countries with 182 international registrations - ROCE improved to 16.1% and ROE to 11.4% in FY26 - Digital initiatives and farmer connect programs expanded - Upcoming plant at Sotanala to boost manufacturing capacity
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 INSECTICID — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add INSECTICID to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Insecticides (India) Limited

Important. The summary above is generated automatically from Insecticides (India) Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.